Oral Fluconazole 100-200 mg Daily for 7-14 Days
For an adult with oral thrush without liver disease or contraindications, oral fluconazole is the first-line pill treatment, dosed at 100-200 mg daily for 7-14 days. 1
Treatment Algorithm Based on Disease Severity
Mild Oral Thrush
- While topical agents (clotrimazole troches, miconazole buccal tablets) are recommended for mild disease 1, these are not pills
- If you specifically need a pill for mild disease, use fluconazole 100 mg daily for 7-14 days (lower end of dosing range)
Moderate to Severe Oral Thrush
- Fluconazole 100-200 mg daily for 7-14 days is the guideline-recommended oral pill 1
- This carries a strong recommendation with high-quality evidence
- Use the higher dose (200 mg) for more severe presentations
Why Fluconazole is First-Line
The 2016 IDSA guidelines clearly establish fluconazole as the systemic oral agent of choice for oral candidiasis 1. This recommendation is supported by:
- Superior efficacy: Clinical cure rates of 87% with fluconazole versus 52% with nystatin in HIV-infected patients 2
- Better mycological clearance: 60% eradication rate versus 6% with topical nystatin 2
- Longer disease-free interval: 18% relapse rate at day 28 versus 44% with nystatin 2
- Better patient compliance: Patients report significantly less inconvenience with fluconazole compared to topical agents 3
Important Clinical Considerations
When to Use Higher Doses
- Immunosuppressed patients (HIV, transplant recipients, chemotherapy)
- More extensive oral involvement
- Esophageal extension suspected (though this requires 200-400 mg daily for 14-21 days) 1
Resistance Patterns
- Candida krusei is intrinsically resistant to fluconazole 4
- Candida glabrata often shows reduced susceptibility 4
- If fluconazole fails, consider itraconazole solution 200 mg once daily or posaconazole as second-line agents 1
Common Pitfall
Do not use fluconazole prophylactically for recurrent thrush without addressing underlying causes, as this promotes resistance development 5. Resistance occurs most commonly in patients with low CD4 counts on chronic fluconazole prophylaxis 5.
Special Populations
- HIV patients: Antiretroviral therapy is essential to reduce recurrence 1
- Denture wearers: Must disinfect dentures in addition to antifungal therapy 1
- Palliative care patients: Single-dose fluconazole 150 mg showed 96.5% improvement in symptoms, offering a simplified regimen for those with high pill burden 6